Pharma: Rare Disease
Tripling Patient Engagement with VG Health
The Mission
Educate Rare Disease Patients
A leading pharmaceutical brand set out to reach people affected by a rare, often underdiagnosed disease and guide them to educational resources most relevant to their situation.
The Solution
Match Resources and Messaging To The Patient Journey
To better understand the audience, VG Health asked questions that led to helpful articles and qualified patients for more personalized messaging across digital channels.
- People experiencing symptoms received educational content about the disease and encouragement to speak with a healthcare provider.
- Patients exploring treatment options saw messaging that introduced therapies worth discussing with their care team.
- Patients already in treatment received branded messaging focused on the therapy itself.
The Results
Better Patient Signals Tripled Engagement
By matching educational content and messaging to patients’ journey stages, the brand created a more relevant experience for each audience. Compared to other programmatic partners, ViralGains delivered:
- 2.2× Higher Audience Quality (Crossix)
- 3.2× Higher Engaged Site Reach
Interested in learning more about this campaign?
Browse our other case studies.
Pharma: Rare Disease Tripling Patient Engagement with VG HealthPharma
Pharma: NeurologyReaching Migraine Patients with Precision and Driving Real-World Health OutcomesPharma
Pharma: RheumatologyBoosting Audience Quality by 3x with Zero-Party Data and VoiceAlike® AIPharma
Financial Services BrandOptimizing Ad Campaigns with Zero-Party DataFinance
IPG Media Lab & MAGNAA Study on Improving Brand Perception
Auto BrandDriving Brand Love and Brand Lift with Interactive VideoAuto
Travel BrandGauging travel intent & influencing brand preference.Travel
Retail BrandEngaging new customers to shop in-store for the holidays. Retail
B2B Software BrandFinding and Influencing Prospective Software CustomersTechnology
Technology BrandDriving Brand Affinity Among Different Target AudiencesTechnology